Disaster and Military Medicine welcomes well-described case studies. These will usually present a major programme intervention or policy option relevant to the journal field. Manuscripts that include a rigorous assessment of the processes and the impact of the study, as well as recommendations for the future, will generally be considered favourably.
Preparing your manuscript
The title page should:
- present a title that includes, if appropriate, the study design e.g.:
- "A versus B in the treatment of C: a randomized controlled trial", "X is a risk factor for Y: a case control study", "What is the impact of factor X on subject Y: A systematic review, A case report etc."
- or, for non-clinical or non-research studies: a description of what the article reports
- list the full names, institutional addresses and email addresses for all authors:
- if a collaboration group should be listed as an author, please list the Group name as an author. If you would like the names of the individual members of the Group to be searchable through their individual PubMed records, please include this information in the “Acknowledgements” section in accordance with the instructions below
- indicate the corresponding author
The Abstract should not exceed 350 words. Please do not use abbreviations or references in the abstract. The abstract should be structured into separate sections as the overall structure of the article: Background, Case description, Discussion and Evaluation, Conclusions.
Three to ten keywords representing the main content of the article.
This should clearly describe the issues being faced so that readers understand the context. It should then explain the rationale for the intervention and should end with a very brief statement of what is being reported in the article. If possible, authors should also present alternative approaches to the one being described.
This should describe the case, including the role of the people and institutions involved and how the intervention was analysed. Cost data are particularly useful for such an assessment, if available. This section may be broken into subsections with subheadings.
Discussion and Evaluation
This should describe the pros and the cons of the intervention, with a realistic evaluation of its feasibility and effectiveness.
This should state what was learnt, what the next steps should be, and, if possible, what contingency planning may be required for those steps.
List of abbreviations
If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.
Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must:
- include a statement on ethics approval and consent (even where the need for approval was waived)
- include the name of the ethics committee that approved the study and the committee’s reference number if appropriate
Studies involving animals must include a statement on ethics approval.
See our editorial policies for more information.
If your manuscript does not report on or involve the use of any animal or human data or tissue, this section is not applicable to your submission. Please state “Not applicable” in this section.
Consent for publication
If your manuscript contains any individual person’s data in any form, consent to publish must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent to publish. You can use your institutional consent form or our consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).
If your manuscript does not contain any individual persons data, please state “Not applicable” in this section.
Availability of data and materials
For all journals, BioMed Central strongly encourages all datasets on which the conclusions of the manuscript rely to be either deposited in publicly available repositories (where available and appropriate) or presented in the main paper or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible. Please see the list of recommended repositories in our editorial policies.
For some journals, deposition of the data on which the conclusions of the manuscript rely is an absolute requirement. Please check the Criteria section for this article type (located at the top of this page) for journal specific policies.
For all journals, authors must include an “Availability of data and materials” section in their article detailing where the data supporting their findings can be found. If you do not wish to share your data, please state that data will not be shared, and state the reason.
For instructions on how to cite your data and format this section see preparation/style and formatting.
All financial and non-financial competing interests must be declared in this section. See our editorial policies for a full explanation of competing interests. If you are unsure whether you or any of your co-authors have a competing interest please contact the editorial office.
All sources of funding for the research reported should be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.
The individual contributions of authors to the manuscript should be specified in this section. Guidance and criteria for authorship can be found in our editorial policies.
Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.
See our editorial policies for a full explanation of acknowledgements and authorship criteria.
Group authorship: if you would like the names of the individual members of a collaboration Group to be searchable through their individual PubMed records, please ensure that the title of the collaboration Group is included on the title page and in the submission system and also include collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country information for each author if you wish, but this should be consistent across all authors.
Please note that individual names may not be present in the PubMed record at the time a published article is initially included in PubMed as it takes PubMed additional time to code this information.
You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.
Endnotes should be designated within the text using a superscript lowercase letter and all notes (along with their corresponding letter) should be included in the Endnotes section. Please format this section in a paragraph rather than a list.
For guidance on the appropriate use of references, see our editorial policies.
For instructions on how to format your references, see preparation/style and formatting information.
Illustrations and figures (if any)
See preparation/style and formatting for information on how to format your figures.
Tables and captions
See preparation/style and formatting for information on how to format your tables.
2017 Journal Metrics
97 days to first decision for reviewed manuscripts only
88 days to first decision for all manuscripts
92 days from submission to acceptance
10 days from acceptance to publication
75 Altmetric Mentions